A comparison of the effects of oral prednisone and inhaled beclomethasone dipropionate on circulating leukocytes

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 6, 1996, Pages 800-805

  Cameron, R G ^a   Black, P N ^a,b   Braan, C ^b   Browett, P J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

beclomethasone dipropionate; lymphocytes; neutrophils; prednisone; systemic effects

Indexed keywords

BECLOMETASONE DIPROPIONATE; PLACEBO; PREDNISONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE; LYMPHOCYTE COUNT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION;

EID: 0030450714     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb00628.x     Document Type: Article

References (25)

1. Smith MJ, Hodson ME. Effects of long term high dose beclomethasone dipropionate on adrenal function. Thorax 1983; 38: 676-81.
2. Ebden P, Jenkins A, Houston G, Davies BH. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500μg/day) and budesonide (1600μg/day) for chronic asthma. Thorax 1986; 41: 869-74.
3. Reid DM, Nicoll JJ, Smith JJ, Higgins B, Tothill P, Nuki G. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia. Br Med J 1986; 293: 1463-6.
4. Pouw EM, Prummel MF, Oosting H, Roos CH, Endert E. Beclomethasone inhalation decreases serum osteocalcin concentrations. Br Med J 1991; 302: 627-8.
5. Capewell S, Reynolds S, Shuttleworth D, Edwards C, Finlay AY. Purpura and dermal thinning associated with high dose inhaled corticosteroids. Br Med J 1990; 300: 1548-51.
6. Blaiss MS, Herrod HG, Crawford LV, Lieberman PL. Beclomethasone dipropionate aerosol: hematologic and immunologic effects. Ann Allergy 1982; 48: 210-4.
7. Harris DM. Some properties of beclomethasone dipropionate and related steroids in man. Postgrad Med J 1975; 51 (Suppl 4): 20-5.
8. Dale DC, Fauci AS, Guerry D et al. Comparison of agents producing a neutrophilic leukocytosis in man: hydrocortisone, prednisone, endotoxin and etiocholanolone. J Clin Invest 1975; 56: 808-13.
9. Slade JD, Hepburn B. Prednisone-induced alterations of circulating human lymphocyte subsets. J Lab Clin Med 1983; 101: 479-87.
10. British Thoracic and Tuberculosis Association. Inhaled corticosteroids compared with oral prednisolone in patients starting long term corticosteroids for asthma. Lancet 1975; ii: 469-73.
11. Dolovich M, Ruffin RE, Roberts R, Newhouse MT. Optimal delivery of aerosols from metered dose inhalers. Chest 1981; 80 (Suppl 65): 911-15.
12. Martin LE, Tanner RJN, Clark TJH, Cochrane GM. Absorption and metabolism of orally administered beclomethasone dipropionate. Clin Pharmacol Ther 1974; 15: 267-75.
13. Wong J, Black P. Acute adrenal insufficiency associated with high dose inhaled steroids. Br Med J 1992; 304: 1415.
14. Evans PM, O'Connor BJ, Fuller RW, Barnes PJ, Chung KF. Effect of inhaled corticosteroids on peripheral blood eosinophil counts and the density profiles in asthma. J Allergy Clin Immunol 1993; 19: 643-5.
15. Harris TAJ, Fuller RW. A review of the clinical experience with therapeutic doses of fluticasone propionate and budesonide and their effect on serum cortisol. Eur Respir J 1996; 9 (Suppl 23): 53s (Abstr.).
16. Elwood RK, Kennedy S, Beltzberg A, Hogg JC, Pare PD. Respiratory mucosal permability in asthma. Am Rev Respir Dis 1983; 128: 523-7.
17. O'Byrne PM, Dolovich M, Dirks R, Roberts RS, Newhouse MT. Lung permability: relation to nonspecific airway responsiveness. J Appl Physiol 1984; 57: 77-84.
18. Johannson SA, Andersson KE, Brattsand R, Gruvstad E, Hedner P. Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Eur J Respir Dis 1982; (Suppl 122): 74-82.
19. Ryrfeldt A, Andersson P, Edsbacker S, Tonneson M, Davies D, Pauwels R. Rharmacokinetics and metabolism of budesonide; a selective glucocorticoid. Eur J Respir Dis 1982; 63 (Suppl 122): 86-95.
20. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson S-A. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol 1989; 84: 688-700.
21. Esteban NV, Loughlin T, Yergey AL et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991; 72: 39-45.
22. Schimmer BP, Parker KL. Adrenocorticotrophic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Oilman AG (Eds). The pharmacological basis of therapeutics. New York: McGraw-Hill, 1996: 1459-1485.
23. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 1995; 22: 1055-9.
24. Spector TD, Sambrook PN. Steroid osteoporosis. Br Med J 1993; 307:519-20.
25. Selroos O, Halme M. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Thorax 1991; 46: 891-4.